drugset / Trial / NCT00374855
A Study in People With Mild Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to test the hypothesis that LY518674, administered for 6 weeks to patients with mild hypertension, reduces Systolic Blood Pressure, compared with placebo.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | — | — |
| Subject | LY518674 | Small molecule | — | — |